BostonGene and Kyoto University have entered a research collaboration to develop advanced biological signatures.

TandemAI has secured a $22 million Series A extension to further develop its drug discovery platform, which combines advanced ...

Q Earnings: $5.8 billion (+83%) YTD Revenues: $48.6 billion (flat) YTD Earnings: $15.3 (+14%) Comments: KEYTRUDA sales were ...

Merck has entered a definitive agreement to acquire Cidara Therapeutics, a biotechnology company developing drug-Fc conjugate ...

3Q Earnings: $186 million (earnings were $1.6B 3Q24) YTD Revenues: $44.5 billion (+8%) YTD Earnings: $2.4 billion (-44%) ...

The U.S. Department of Health and Human Services (HHS) and the U.S. FDA, has appointed Richard Pazdur, M.D., as director of ...

Domain Therapeutics, a clinical-stage biopharmaceutical company, has appointed Jean-Marie Cuillerot, M.D., as Chief Medical ...

Neurvati Neurosciences, the neuroscience development platform of Blackstone Life Sciences, appointed Carlos Martin as Chief ...

Ji will drive strategic planning, operations, and the continued expansion of the company’s development and manufacturing ...

Panthera Biopartners, a UK Site Management Organization (SMO) which runs commercial clinical trials for the pharmaceutical ...

Leukogene Therapeutics Inc., a biopharmaceutical company developing next-generation therapies for hematologic and other ...

Abzena, an integrated CDMO for complex biologics and bioconjugates, and Mabqi, a biotechnology company focused on developing ...